AAAAAA
Results: 1-25/41
Authors:
GANDHI V
XU YZ
ESTEY E
Citation: V. Gandhi et al., ACCUMULATION OF ARABINOSYLURACIL 5'-TRIPHOSPHATE DURING ARABINOSYLCYTOSINE THERAPY IN CIRCULATING BLASTS OF PATIENTS WITH ACUTE MYELOGENOUSLEUKEMIA, Clinical cancer research, 4(7), 1998, pp. 1719-1726
Authors:
GANDHI V
PLUNKETT W
KANTARJIAN H
TALPAZ M
ROBERTSON LE
OBRIEN S
Citation: V. Gandhi et al., CELLULAR PHARMACODYNAMICS AND PLASMA PHARMACOKINETICS OF PARENTERALLYINFUSED HYDROXYUREA DURING A PHASE-I CLINICAL-TRIAL IN CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 16(7), 1998, pp. 2321-2331
Authors:
GANDHI V
PLUNKETT W
RODRIGUEZ CO
NOWAK BJ
DU M
AYRES M
KISOR DF
MITCHELL BS
KURTZBERG J
KEATING MJ
Citation: V. Gandhi et al., COMPOUND GW506U78 IN REFRACTORY HEMATOLOGIC MALIGNANCIES - RELATIONSHIP BETWEEN CELLULAR PHARMACOKINETICS AND CLINICAL-RESPONSE, Journal of clinical oncology, 16(11), 1998, pp. 3607-3615
Authors:
BOBOFCHAK K
GANDHI V
ZHAO L
OLSEN KW
Citation: K. Bobofchak et al., MOLECULAR-DYNAMICS SIMULATIONS OF CROSS-LINKED AND ABNORMAL-HEMOGLOBINS, Biophysical journal, 74(2), 1998, pp. 84-84
Authors:
GANDHI V
ESTEY E
DU M
KEATING MJ
PLUNKETT W
Citation: V. Gandhi et al., MINIMUM DOSE OF FLUDARABINE FOR THE MAXIMAL MODULATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE TRIPHOSPHATE IN HUMAN LEUKEMIA BLASTS DURING THERAPY, Clinical cancer research, 3(9), 1997, pp. 1539-1545
Authors:
GANDHI V
HUANG P
CHAPMAN AJ
CHEN F
PLUNKETT W
Citation: V. Gandhi et al., INCORPORATION OF FLUDARABINE AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATES BY DNA-POLYMERASE-ALPHA - AFFINITY, INTERACTION, AND CONSEQUENCES, Clinical cancer research, 3(8), 1997, pp. 1347-1355
Authors:
RODRIGUEZ CO
LEGHA JK
ESTEY E
KEATING MJ
GANDHI V
Citation: Co. Rodriguez et al., PHARMACOLOGICAL AND BIOCHEMICAL STRATEGIES TO INCREASE THE ACCUMULATION OF ARABINOFURANOSYLGUANINE TRIPHOSPHATE IN PRIMARY HUMAN LEUKEMIA-CELLS, Clinical cancer research, 3(11), 1997, pp. 2107-2113
Authors:
PLUNKETT W
HUANG P
GANDHI V
Citation: W. Plunkett et al., GEMCITABINE - ACTIONS AND INTERACTIONS, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1261-1270
Authors:
FISHER MA
LEEHEY DJ
GANDHI V
ING T
Citation: Ma. Fisher et al., PHRENIC-NERVE PALSIES AND PERSISTENT RESPIRATORY-ACIDOSIS IN A PATIENT WITH DIABETES-MELLITUS, Muscle & nerve, 20(7), 1997, pp. 900-902
Authors:
GANDHI V
RODRIGUEZ CO
KISOR DF
KEATING MJ
PLUNKETT W
Citation: V. Gandhi et al., RATIONALE AND DESIGN OF PHARMACOLOGICALLY DIRECTED CLINICAL-TRIALS OFGW506U IN REFRACTORY HEMATOLOGIC MALIGNANCIES, Blood, 90(10), 1997, pp. 3823-3823
Authors:
GANDHI V
OLSEN KW
Citation: V. Gandhi et Kw. Olsen, MOLECULAR-DYNAMICS OF THE HAMMERHEAD RIBOZYME, Biophysical journal, 72(2), 1997, pp. 478-478
Authors:
PLUNKETT W
GANDHI V
Citation: W. Plunkett et V. Gandhi, PHARMACOLOGY OF PURINE NUCLEOSIDE ANALOGS, HEM CELL TH, 38, 1996, pp. 67-74
Authors:
KEATING MJ
OBRIEN S
MCLAUGHLIN P
DIMOPOULOS M
GANDHI V
PLUNKETT W
LERNER S
KANTARJIAN H
ESTEY E
Citation: Mj. Keating et al., CLINICAL-EXPERIENCE WITH FLUDARABINE IN HEMATOONCOLOGY, HEM CELL TH, 38, 1996, pp. 83-91
Authors:
SEYMOUR JF
HUANG P
PLUNKETT W
GANDHI V
Citation: Jf. Seymour et al., INFLUENCE OF FLUDARABINE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF CYTARABINE - IMPLICATIONS FOR A CONTINUOUS-INFUSION SCHEDULE, Clinical cancer research, 2(4), 1996, pp. 653-658
Authors:
KORNBLAU SM
GANDHI V
ANDREEFF HM
BERAN M
KANTARJIAN HM
KOLLER CA
OBRIEN S
PLUNKETT W
ESTEY E
Citation: Sm. Kornblau et al., CLINICAL AND LABORATORY STUDIES OF 2-CHLORODEOXYADENOSINE+ -CYTOSINE-ARABINOSIDE FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA IN ADULTS/, Leukemia, 10(10), 1996, pp. 1563-1569
Authors:
KURTZBERG J
KEATING MJ
PLUNKETT W
GANDHI V
GOLD S
REESE M
ELION G
MITCHELL B
Citation: J. Kurtzberg et al., COMPOUND-506 (2-AMINO-6-METHOXYPURINE ARABINOSIDE) IS ACTIVE AGAINST RESISTANT T-CELL MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL, Journal of clinical oncology, 14(5), 1996, pp. 2022-2022
Authors:
LOUGHLIN S
GANDHI V
PLUNKETT W
ZWELLING LA
Citation: S. Loughlin et al., THE EFFECT OF 9-BETA-D-ARABINOFURANOSYL 2-FLUOROADENINE AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE ON THE CELL-CYCLE PHASE DISTRIBUTION, TOPOISOMERASE-II LEVEL, MITOXANTRONE CYTOTOXICITY, AND DNA STRAND BREAK PRODUCTION IN K562 HUMAN LEUKEMIA-CELLS, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 261-268
Authors:
PLUNKETT W
HUANG P
SEARCY CE
GANDHI V
Citation: W. Plunkett et al., GEMCITABINE - PRECLINICAL PHARMACOLOGY AND MECHANISMS OF ACTION, Seminars in oncology, 23(5), 1996, pp. 3-15
Authors:
GANDHI V
LEGHA J
CHEN F
HERTEL LW
PLUNKETT W
Citation: V. Gandhi et al., EXCISION OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) MONOPHOSPHATE RESIDUES FROM DNA, Cancer research, 56(19), 1996, pp. 4453-4459
Authors:
KURTZBERG J
KEATING M
MOORE JO
GANDHI V
BLANEY S
GOLD S
ERNST T
HENSLEEDOWNEY J
CHANG A
KISOR D
PLUNKETT W
MITCHELL B
Citation: J. Kurtzberg et al., 2-AMINO-9-B-D-ARABINOSYL-6-METHOXY-9H-GUANINE (GW 506U COMPOUND 506U)IS HIGHLY-ACTIVE IN PATIENTS WITH T-CELL MALIGNANCIES - RESULTS OF A PHASE-I TRIAL IN PEDIATRIC AND ADULT PATIENTS WITH REFRACTORY HEMATOLOGICAL MALIGNANCIES, Blood, 88(10), 1996, pp. 2666-2666
Authors:
GANDHI V
KISOR DF
RODRIGUEZ CO
MITCHELL BS
KURTZBERG J
KEATING MJ
PLUNKETT W
Citation: V. Gandhi et al., PHARMACOKINETICS OF ARABINOSYLGUANINE (ARA-G) AND ITS TRIPHOSPHATE (ARA-GTP) DURING A PHASE-I TRIAL OF COMPOUND GW506U IN REFRACTORY HEMATOLOGIC MALIGNANCIES - CORRELATION WITH RESPONSE, Blood, 88(10), 1996, pp. 2667-2667
Authors:
GANDHI V
ESTEY E
KEATING MJ
CHUCRALLAH A
PLUNKETT W
Citation: V. Gandhi et al., CHLORODEOXYADENOSINE AND ARABINOSYLCYTOSINE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA - PHARMACOKINETIC, PHARMACODYNAMIC, AND MOLECULAR-INTERACTIONS, Blood, 87(1), 1996, pp. 256-264
Authors:
GANDHI V
ESTEY E
DU M
NOWAK B
KEATING MJ
PLUNKETT W
Citation: V. Gandhi et al., MODULATION OF THE CELLULAR-METABOLISM OF CYTARABINE AND FLUDARABINE BY GRANULOCYTE-COLONY-STIMULATING FACTOR DURING THERAPY OF ACUTE MYELOGENOUS LEUKEMIA, Clinical cancer research, 1(2), 1995, pp. 169-178
Authors:
PLUNKETT W
HUANG P
GANDHI V
Citation: W. Plunkett et al., PRECLINICAL CHARACTERISTICS OF GEMCITABINE, Anti-cancer drugs, 6, 1995, pp. 7-13
Authors:
PLUNKETT W
HUANG P
XU YZ
HEINEMANN V
GRUNEWALD R
GANDHI V
Citation: W. Plunkett et al., GEMCITABINE - METABOLISM, MECHANISMS OF ACTION, AND SELF-POTENTIATION, Seminars in oncology, 22(4), 1995, pp. 3-10